The glucocorticoid receptor gene and its association to metabolic syndrome

Obesity Research

Volumn 10, Issue 10, 2002, Pages 1078-1086

  Rosmond, Roland ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gene; Glucocorticoid receptor; Hypertension; Insulin resistance; Mutation

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

ALLELE; FEMALE; GENETICS; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MUTATION; OBESITY; PHYSIOLOGY; REVIEW;

ALLELES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METABOLIC SYNDROME X; MUTATION; OBESITY; RECEPTORS, GLUCOCORTICOID;

EID: 0036777944     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2002.146     Document Type: Review

References (82)

1. Hollenberg SM, Weinberger C, Ong ES, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 1985;318:635-41.
2. Carson-Jurica M, Schrader W, O'Malley B. Steroid receptor family: structure and functions. Endocrinol Rev. 1990;11: 201-20.
3. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 1994;63:451-86.
4. Muller M, Renkawitz R. The glucocorticoid receptor. Biochim Biophys Acta. 1991;1088:171-82.
5. Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem. 1996;271:9550-9.
6. Rivers C, Levy A, Hancock J, Lightman S, Norman M. Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J Clin Endocrinol Metab. 1999;84:4283-6.
7. Francke U, Foellmer BE. The glucocorticoid receptor gene is in 5q31-q32. Genomics. 1989;4:610-2.
8. Encio IJ, Detera-Wadleigh SD. The genomic structure of the human glucocorticoid receptor. J Biol Chem. 1991;266:7182-8.
9. Rousseau GG. Structure and regulation of the glucocorticoid hormone receptor. Mol Cell Endocrinol. 1984;38:1-11.
10. Giguere V, Hollenberg SM, Rosenfeld MG, Evans RM. Functional domains of the human glucocorticoid receptor. Cell. 1986;46:645-52.
11. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell. 1998;93:487-90.
12. Toft DO. Recent advances in the study of hsp90 structure and mechanism of action. Trends Endocrinol Metab. 1998;9:238-43.
13. Pratt WB, Dittmar KD. Studies with purified chaperones advance the understanding of the mechanism of glucocorticoid receptor-hsp90 heterocomplex assembly. Trends Endocrinol Metab. 1998;9:244-52.
14. Pratt WB, Toft DO. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocrinol Rev. 1997;18:306-60.
15. Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell. 1995;83:851-7.
16. Beato M, Chavez S, Truss M. Transcriptional regulation by steroid hormones. Steroids. 1996;61:240-51.
17. Björntorp P, Bengtsson C, Blohme G, et al. Adipose tissue fat cell size and number in relation to metabolism in randomly selected middle-aged men and women. Metabolism. 1971;20: 927-35.
18. Björntorp P. The associations between obesity, adipose tissue distribution and disease. Acta Med Scand Suppl. 1988;723: 121-34.
19. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
20. Rusmond R. Visceral obesity and the metabolic syndrome. In: Björntorp P, ed. The International Textbook of Obesity. Chichester: John Wiley & Sons; 2001, pp. 339-50.
21. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1 : Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1999.
22. Beck-Nielsen H. General characteristics of the insulin resistance syndrome: prevalence and heritability. European Group for the study of Insulin Resistance (EGIR). Drugs. 1999;58: 7-10.
23. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
24. Vanhala MJ, Kumpusalo EA, Pitkajarvi TK, Takala JK. Metabolic syndrome in a middle-aged Finnish population. J Cardiovasc Risk. 1997;4:291-5.
25. Wannamethee SG, Shaper AG, Durrington PN, Perry IJ. Hypertension, serum insulin, obesity and the metabolic syndrome. J Hum Hypertens. 1998;12:735-41.
26. Koutis AD, Lionis CD, Isacsson A, Jakobsson A, Fioretos M, Lindholm LH. Characteristics of the 'metabolic syndrome X' in a cardiovascular low risk population in Crete. Eur Heart J. 1992;13:865-71.
27. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523-9.
28. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol. 1998;148:958-66.
29. Yarbrough DE, Barrett-Connor E, Kritz-Silverstein D, Wingard DL. Birth weight, adult weight, and girth as predictors of the metabolic syndrome in postmenopausal women: the Rancho Bernardo Study. Diabetes Care. 1998;21:1652-8.
30. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the West Bank population: an urban-rural comparison. Diabetes Care. 2001;24:275-9.
31. Lee ZS, Critchley JA, Chan JC, et al. Obesity is the key determinant of cardiovascular risk factors in the Hong Kong Chinese population: cross-sectional clinic-based study. Hong Kong Med J. 2000;6:13-23.
32. Hurley DM, Accili D, Stratakis CA, et al. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 1991;87:680-6.
33. Karl M, Lamberts SW, Koper JW, et al. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians. 1996;108:296-307.
34. Ruiz M, Lind U, Gafvels M, et al. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol (Oxf). 2001; 55:363-71.
35. Malchoff DM, Brufsky A, Reardon G, et al. A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest. 1993;91:1918-25.
36. Koper JW, Stolk RP, de Lange P, et al. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet. 1997;99:663-8.
37. de Lange P, Koper JW, Huizenga NA, et al. Differential hormone-dependent transcriptional activation and repression by naturally occurring human glucocorticoid receptor variants. Mol Endocrinol. 1997;11:1156-64.
38. Vingerhoeds AC, Thijssen JH, Schwarz F. Spontaneous hypercortisolism without Cushing's syndrome. J Clin Endocrinol Metab. 1976;43:1128-33.
39. Chrousos GP, Vingerhoeds A, Brandon D, et al. Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. J Clin Invest. 1982;69:1261-9.
40. Chrousos GP, Detera-Wadleigh SD, Karl M. Syndromes of glucocorticoid resistance. Ann Intern Med. 1993;119:1113-24.
41. Werner S, Brönnegard M. Molecular basis of glucocorticoid-resistant syndromes. Steroids. 1996;61:216-21.
42. Kino T, Chrousos GP. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. J Endocrinol. 2001; 169:437-45.
43. Lamberts SW, Koper JW, Biemond P, den Holder FH, de Jong FH. Cortisol receptor resistance: the variability of its clinical presentation and response to treatment. J Clin Endocrinol Metab. 1992;74:313-21.
44. Lamberts SW, Huizenga AT, de Lange P, de Jong FH, Koper JW. Clinical aspects of glucocorticoid sensitivity. Steroids. 1996;61:157-60.
45. Dahia PL, Honegger J, Reincke M, et al. Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors. J Clin Endocrinol Metab. 1997;82:1088-93.
46. Huizenga NA, de Lange P, Koper JW, et al. Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus. J Clin Endocrinol Metab. 1998;83:917-21.
47. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332: 1351-62.
48. Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann NY Acad Sci. 1998;851:311-35.
49. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171-9.
50. Pepin MC, Pothier F, Barden N. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature. 1992;355:725-8.
51. Montkowski A, Barden N, Wotjak C, et al. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol. 1995;7:841-5.
52. Tronche F, Kellendonk C, Kretz O, et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet. 1999;23:99-103.
53. Kenyon CJ, Panarelli M, Zagato L, et al. Glucocorticoid receptor polymorphism in genetic hypertension. J Mol Endocrinol. 1998;21:41-50.
54. Ray DW, Davis JR, White A, Clark AJ. Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells. Cancer Res. 1996;56:3276-80.
55. Jiang T, Liu S, Tan M, et al. The phase-shift mutation in the glucocorticoid receptor gene: potential etiologic significance of neuroendocrine mechanisms in lupus nephritis. Clin Chim Acta. 2001;313:113-7.
56. Björntorp P, Rosmond R. Obesity and cortisol. Nutrition. 2000;16:924-36.
57. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science. 2001;294:2166-70.
58. Weaver JU, Hitman GA, Kopelman PG. An association between a BclI restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J Mol Endocrinol. 1992;9:295-300.
59. Clement K, Philippi A, Jury C, et al. Candidate gene approach of familial morbid obesity: linkage analysis of the glucocorticoid receptor gene, Int J Obes Relat Metab Disord. 1996;20:507-12.
60. Buemann B, Vohl MC, Chagnon M, et al. Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res. 1997;5:186-92.
61. Panarelli M, Holloway CD, Fraser R, et al. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab. 1998;83:1846-52.
62. Rosmond R, Chagnon YC, Holm G, et al. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res. 2000;8:211-8.
63. Ukkola O, Rosmond R, Tremblay A, Bouchard C. Glucocorticoid receptor BclI variant is associated with an increased atherogenic profile in response to long-term overfeeding. Atherosclerosis. 2001;157:221-4.
64. Bouchard C, Tremblay A, Després JP, et al. The response to long-term overfeeding in identical twins. N Engl J Med. 1990;322:1477-82.
65. Karl M, Lamberts SW, Detera-Wadleigh SD, et al. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab. 1993;76:683-9.
66. Huizenga NA, Koper JW, De Lange P, et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab. 1998;83:144-51.
67. Lin RC, Wang WY, Morris BJ. Association and linkage analyses of glucocorticoid receptor gene markers in essential hypertension. Hypertension. 1999;34:1186-92.
68. Lin RC, Wang WY, Morris BJ. High penetrance, overweight, and glucocorticoid receptor variant: case-control study. BMJ. 1999;319:1337-8.
69. Halsall DJ, Luan J, Hales N, Wareham NJ, O'Rahilly S. Glucocorticoid receptor variant and body mass index. BMJ. 2000. http:// www.bmj.com/cgi/eletters/319/7221/1337#9433
70. Dobson MG, Redfern CP, Unwin N, Weaver JU. The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J Clin Endocrinol Metab. 2001;86:2270-4.
71. Rosmond R, Bouchard C, Björntorp P. Tsp509I polymorphism in exon 2 of the glucocorticoid receptor gene in relation to obesity and cortisol secretion: cohort study. BMJ. 2001; 322:652-3.
72. Echwald SM, Sorensen TI, Andersen T, Pedersen O. The Asn363Ser variant of the glucocorticoid receptor gene is not associated with obesity or weight gain in Danish men. Int J Obes Relat Metab Disord. 2001;25:1563-5.
73. Takami S, Wong ZY, Stebbing M, Harrap SB. Linkage analysis of glucocorticoid and β2-adrenergic receptor genes with blood pressure and body mass index. Am J Physiol. 1999;276:H1379-H84.
74. Chalew S, Nagel H, Shore S. The hypothalamic-pituitary-adrenal axis in obesity. Obes Res. 1995;3:371-82.
75. Armanini D, Spinella P, Simoncini M, et al. Regulation of corticosteroid receptors in patients with anorexia nervosa and Cushing's syndrome. J Endocrinol. 1998;158:435-9.
76. Masi AT, Chrousos GP, Bornstein SR. Enigmas of adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis. J Rheumatol. 1999;26:247-50.
77. Zobel AW, Yassouridis A, Frieboes RM, Holsboer F. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am J Psychiatr. 1999;156:949-51.
78. Fraser R, Ingram MC, Anderson NH, Morrison C, Davies E, Connell JM. Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension. 1999; 33:1364-8.
79. Björntorp P, Holm G, Rosmond R. Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus. Diabetes Med. 1999;16:373-83.
80. Rosmond R, Björntorp P. Alterations in the hypothalamic-pituitary-adrenal axis in Metabolic Syndrome. Endocrinologist. 2001;11:491-7.
81. Murray JC, Smith RF, Ardinger HA, Weinberger C. RFLP for the glucocorticoid receptor (GRL) located at 5q11-5q13. Nucleic Acids Res. 1987;15:6765.
82. Watt GC, Harrap SB, Foy CJ, et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens. 1992;10: 473-82.